Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

Ramiro Garzon (Opfinder), Adrienne Dorrance (Opfinder), Dimitrios Papaioannou (Opfinder), Robert Lee (Opfinder), Sakari Kauppinen (Opfinder), Andreas Petri (Opfinder), Charlotte Albæk Thrue (Opfinder)

Publikation: Patent

Resumé

The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

OriginalsprogEngelsk
IPCC12N 15/ 113 A I
PatentnummerWO2018085656
Journaliseringsdato11/05/2018
LandDanmark
Prioritetsdato03/11/2016
PrioritetsnummerUS201662416993P
StatusUdgivet - 2018

Fingerprint

Long Noncoding RNA
Untranslated RNA
Disclosure
Acute Myeloid Leukemia

Citer dette

Garzon, R., Dorrance, A., Papaioannou, D., Lee, R., Kauppinen, S., Petri, A., & Albæk Thrue, C. (2018). IPC nr. C12N 15/ 113 A I. Antisense oligomers targeting HOXB-AS3 lon non-coding RNA. (Patentnummer WO2018085656).
Garzon, Ramiro (Opfinder) ; Dorrance, Adrienne (Opfinder) ; Papaioannou, Dimitrios (Opfinder) ; Lee, Robert (Opfinder) ; Kauppinen, Sakari (Opfinder) ; Petri, Andreas (Opfinder) ; Albæk Thrue, Charlotte (Opfinder). / Antisense oligomers targeting HOXB-AS3 lon non-coding RNA. IPC nr.: C12N 15/ 113 A I. Patentnummer: WO2018085656. maj 11, 2018.
@misc{cce5ad290e5b4078ad8df938d95ac688,
title = "Antisense oligomers targeting HOXB-AS3 lon non-coding RNA",
abstract = "The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.",
author = "Ramiro Garzon and Adrienne Dorrance and Dimitrios Papaioannou and Robert Lee and Sakari Kauppinen and Andreas Petri and {Alb{\ae}k Thrue}, Charlotte",
year = "2018",
language = "English",
type = "Patent",
note = "WO2018085656; C12N 15/ 113 A I",

}

Garzon, R, Dorrance, A, Papaioannou, D, Lee, R, Kauppinen, S, Petri, A & Albæk Thrue, C maj. 11 2018, Antisense oligomers targeting HOXB-AS3 lon non-coding RNA, Patentnummer WO2018085656, IPC nr. C12N 15/ 113 A I.

Antisense oligomers targeting HOXB-AS3 lon non-coding RNA. / Garzon, Ramiro (Opfinder); Dorrance, Adrienne (Opfinder); Papaioannou, Dimitrios (Opfinder); Lee, Robert (Opfinder); Kauppinen, Sakari (Opfinder); Petri, Andreas (Opfinder); Albæk Thrue, Charlotte (Opfinder).

IPC nr.: C12N 15/ 113 A I. Patentnummer: WO2018085656. maj 11, 2018.

Publikation: Patent

TY - PAT

T1 - Antisense oligomers targeting HOXB-AS3 lon non-coding RNA

AU - Garzon, Ramiro

AU - Dorrance, Adrienne

AU - Papaioannou, Dimitrios

AU - Lee, Robert

AU - Kauppinen, Sakari

AU - Petri, Andreas

AU - Albæk Thrue, Charlotte

PY - 2018

Y1 - 2018

N2 - The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

AB - The present disclosure relates to antisense oligomers targeting the long non-coding RNA HOXB-AS3 and methods of treating acute myeloid leukemia.

M3 - Patent

M1 - WO2018085656

Y2 - 2018/05/11

ER -

Garzon R, Dorrance A, Papaioannou D, Lee R, Kauppinen S, Petri A et al, Opfindere. Antisense oligomers targeting HOXB-AS3 lon non-coding RNA. C12N 15/ 113 A I. 2018.